{
    "id": 25295,
    "fullName": "FOLH1 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "FOLH1 positive indicates the presence of the FOLH1 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 2346,
        "geneSymbol": "FOLH1",
        "terms": [
            "FOLH1",
            "FGCP",
            "FOLH",
            "GCP2",
            "GCPII",
            "mGCP",
            "NAALAD1",
            "NAALAdase",
            "PSM",
            "PSMA"
        ]
    },
    "variant": "positive",
    "createDate": "08/30/2016",
    "updateDate": "08/30/2016",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9338,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, J591 resulted in antitumor activity in 57% (20/35) of prostate cancer patients, with four patients demonstrating a decrease in PSA levels and sixteen patients experiencing PSA stabilization (PMID: 15837970).",
            "molecularProfile": {
                "id": 26143,
                "profileName": "FOLH1 positive"
            },
            "therapy": {
                "id": 4981,
                "therapyName": "J591",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 7104,
                    "pubMedId": 15837970,
                    "title": "Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15837970"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8162,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MOR209/ES414 induced T-cell-mediated cytotoxicity towards FOLH1 (PSMA)-positive prostate cancer cell lines in culture, and inhibited tumor growth, prolonged survival in cell line xenograft models (PMID: 27406985).",
            "molecularProfile": {
                "id": 26143,
                "profileName": "FOLH1 positive"
            },
            "therapy": {
                "id": 4651,
                "therapyName": "MOR209/ES414",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6564,
                    "pubMedId": 27406985,
                    "title": "MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27406985"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11022,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, 60.7% (17/28) of prostate cancer patients positive for FOLH1 (PSMA) demonstrated a reduced PSA >50% when treated with 131I-MIP-1095 (PMID: 24577951).",
            "molecularProfile": {
                "id": 26143,
                "profileName": "FOLH1 positive"
            },
            "therapy": {
                "id": 5804,
                "therapyName": "131I-MIP-1095",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9013,
                    "pubMedId": 24577951,
                    "title": "Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24577951"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15365,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BAY 2315497 (PSMA-TTC) inhibited tumor growth in prostate cancer cell line xenograft models expressing high or medium-low levels of FOLH1 (PSMA), and prevented tumor growth in a PSMA-expressing prostate cancer cell line orthotopic bone xenograft model (Cancer Res July 1 2017 (77) (13 Supplement) 5200).",
            "molecularProfile": {
                "id": 26143,
                "profileName": "FOLH1 positive"
            },
            "therapy": {
                "id": 7573,
                "therapyName": "BAY 2315497",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 13109,
                    "pubMedId": null,
                    "title": "Abstract 5200: Preclinical pharmacology of the PSMA-targeted thorium-227 conjugate PSMA-TTC: a novel targeted alpha therapeutic for the treatment of prostate cancer",
                    "url": "http://cancerres.aacrjournals.org/content/77/13_Supplement/5200"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20937,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, P-PSMA-101 CAR-T cell treatment inhibited tumor growth and increased survival in a FOLH1 (PSMA)-positive prostate cancer cell line xenograft model (Cancer Res 2018;78(16 Suppl):Abstract nr A071).",
            "molecularProfile": {
                "id": 26143,
                "profileName": "FOLH1 positive"
            },
            "therapy": {
                "id": 9528,
                "therapyName": "P-PSMA-101 CAR-T cells",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 18202,
                    "pubMedId": null,
                    "title": "PSMA-specific CARTyrin T-stem cell memory therapy eliminates solid tumor in subcutaneous prostate cancer model",
                    "url": "https://cancerres.aacrjournals.org/content/78/16_Supplement/A071"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26143,
            "profileName": "FOLH1 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}